How Does Pre-emptive Plerixafor Affect Stem Cell Mobilization for Myeloma Transplant?
A new study suggests there is a cost and efficiency benefit to pre-emptively administrating plerixafor during stem cell collection.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news
More News: Cancer & Oncology | Legislation | Myeloma | Stem Cell Therapy | Stem Cells | Study | Transplants